A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Status:
RECRUITING
Trial end date:
2027-11-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-986470 in healthy volunteers and participants with sickle cell disease.